113 related articles for article (PubMed ID: 2616824)
1. High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps.
Assoufi BK; Hodson ME
Respir Med; 1989 Sep; 83(5):415-20. PubMed ID: 2616824
[TBL] [Abstract][Full Text] [Related]
2. Salbutamol powder inhaled from the Diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction.
Hansen NC; Andersen PB
Respir Med; 1995 Mar; 89(3):175-9. PubMed ID: 7746909
[TBL] [Abstract][Full Text] [Related]
3. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
Jenkins SC; Heaton RW; Fulton TJ; Moxham J
Chest; 1987 Jun; 91(6):804-7. PubMed ID: 3556051
[TBL] [Abstract][Full Text] [Related]
4. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
5. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
Corris PA; Neville E; Nariman S; Gibson GJ
Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
[TBL] [Abstract][Full Text] [Related]
7. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.
Rodrigo C; Rodrigo G
Am J Emerg Med; 1998 Nov; 16(7):637-42. PubMed ID: 9827736
[TBL] [Abstract][Full Text] [Related]
8. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy.
Goldman JM; Teale C; Muers MF
Respir Med; 1992 Jan; 86(1):33-8. PubMed ID: 1533047
[TBL] [Abstract][Full Text] [Related]
9. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
[TBL] [Abstract][Full Text] [Related]
10. Dose response to inhaled salbutamol in chronic obstructive airways disease.
Teale C; Morrison JF; Page RL; Pearson SB
Postgrad Med J; 1991 Aug; 67(790):754-6. PubMed ID: 1754527
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.
Raimondi AC; Schottlender J; Lombardi D; Molfino NA
Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352
[TBL] [Abstract][Full Text] [Related]
12. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
[TBL] [Abstract][Full Text] [Related]
14. Comparison of salbutamol dry powder aerosol with pressurised aerosol.
Chhabra SK
Indian J Chest Dis Allied Sci; 1993; 35(4):163-6. PubMed ID: 8039816
[TBL] [Abstract][Full Text] [Related]
15. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
Mellén A; Arvidsson P; Palmqvist M; Lötvall J
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Ulrik CS
Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
Chan R; Sousa AR; Mallett S; Hynds P; Homayoun-Valiani F; Tabberer M; Mehta R
Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598
[TBL] [Abstract][Full Text] [Related]
18. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
[TBL] [Abstract][Full Text] [Related]
19. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Baronti A; Grieco A; Vibelli C
Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
Barros MJ; Rees PJ
Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
